Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses
ABSTRACTObjective The prognosis of acute myeloid leukemia (AML) remains poor although the basic and translational research has been highly productive in understanding the genetics and pathopoiesis of AML and a plethora of targeted therapies have been developed. Consequently, it is crucial to deepen...
Main Authors: | Shasha Wu, Jiao Jin, Jing Huang, Guifang Chen, Yan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2235833 |
Similar Items
-
Differential Expression of RSK4 Transcript Isoforms in Cancer and Its Clinical Relevance
by: Sisi Chen, et al.
Published: (2022-11-01) -
RSK Isoforms in Acute Myeloid Leukemia
by: Minyoung Youn, et al.
Published: (2021-06-01) -
A novel necroptosis-related gene signature in acute myeloid leukemia
by: Weiyue Fang, et al.
Published: (2023-12-01) -
Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia
by: Miao Chen, et al.
Published: (2022-12-01) -
Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
by: Yidong Zhu, et al.
Published: (2023-02-01)